Danish Cancer Society   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Copenhagen Denmark (1904)

Organization Overview

First Clinical Trial
1998
NCT01819649
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Danish Cancer Society

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Colorectal Neoplasms (Phase 2)

Fatigue (Phase 3)

Leukemia (Phase 4)

Leukemia, Lymphoid (Phase 4)

Lymphedema (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 12